trending Market Intelligence /marketintelligence/en/news-insights/trending/Mu7A3HPi_HDtsX74VPniIQ2 content esgSubNav
In This List

Daxor chief medical officer dies

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Daxor chief medical officer dies

Daxor Corp. founder and Chief Medical Officer Joseph Feldschuh died Jan. 31.

Feldschuh, who was working on a part-time basis, was the first president and CEO of the company. He was undergoing treatment for pancreatic cancer and unexpectedly developed sepsis during the last two days.

Michael Feldschuh will continue in the president and CEO role.

The transition process for the chief medical officer role was ongoing at the time of Joseph Feldschuh's death, but the company does not expect significant functional difficulties arising from the transition process and is confident in the necessary expertise and resources to meet all foreseeable future needs.